Description
A potent HDAC inhibitor that inhibits HDAC2 and HDAC6 with IC50 values of 0.119 and 434 nM; ineffective against HDAC4 (IC50 = >1,000 nM); inhibits the growth of HCT116 cells and HuT-78 cells (GI50 = 29.4 and 1.4 μM, respectively) more effectively than human dermal fibroblasts (GI50 = >100 μM)
Formal name: N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid, ethyl ester
Synonyms: Santacruzamate A
Molecular weight: 278.4
CAS: 1477949-42-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products|Microbial Metabolites||Product Type|Biochemicals|Small Molecule Inhibitors|Deacetylases||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Research Area|Epigenetics, Transcription, & Translation|Erasers|Histone Deacetylation